Invesco Ltd. Infinity Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $15,228 - $37,293	-31,078 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $49 - $139	-58 Reduced 0.19%	31,078 $35,000
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $565 - $1,021	304 Added 0.99%	31,136 $70,000
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $11,320 - $28,451	7,448 Added 31.85%	30,832 $105,000
Q2 2021 Aug 17, 2021	BUY	$2.66 - $3.47 $62,201 - $81,142	23,384 New	23,384 $70,000
Q1 2019 May 15, 2019	SELL	$1.18 - $1.91 $15,286 - $24,744	-12,955 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.01 - $2.78 $13,084 - $36,014	12,955 New	12,955 $15,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.